KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Receivables (2017 - 2026)

Guardant Health's Receivables history spans 9 years, with the latest figure at $143.0 million for Q4 2025.

  • On a quarterly basis, Receivables rose 25.86% to $143.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $143.0 million, a 25.86% increase, with the full-year FY2025 number at $143.0 million, up 25.86% from a year prior.
  • Receivables hit $143.0 million in Q4 2025 for Guardant Health, up from $120.7 million in the prior quarter.
  • Over the last five years, Receivables for GH hit a ceiling of $143.0 million in Q4 2025 and a floor of $65.8 million in Q1 2021.
  • Historically, Receivables has averaged $100.5 million across 5 years, with a median of $94.0 million in 2023.
  • Biggest five-year swings in Receivables: soared 88.95% in 2021 and later decreased 9.29% in 2023.
  • Tracing GH's Receivables over 5 years: stood at $103.4 million in 2021, then decreased by 0.67% to $102.7 million in 2022, then decreased by 8.74% to $93.7 million in 2023, then grew by 21.32% to $113.7 million in 2024, then increased by 25.86% to $143.0 million in 2025.
  • Business Quant data shows Receivables for GH at $143.0 million in Q4 2025, $120.7 million in Q3 2025, and $134.1 million in Q2 2025.